Mounjaro. Wegovy. Ozempic. A year ago, these were whispered about in celebrity gossip columns. Now they are prescribed by GPs, discussed openly at dinner parties and advertised by private clinics on public transport. GLP-1 medications have entered the mainstream and with them has come a quiet but significant rewiring of how people think about food, bodies, and the marketing messages promoted by lifestyle, food and drink brands.
The opportunity for food brands
GLP-1 users are not disengaging from food, they are re-engaging with it differently.
Reduced appetite tends to sharpen preferences. Smaller portions mean people are less willing to waste their appetite on something they don’t genuinely want. Protein and nutrient density matter more. The incidental, grab-and-go eating that much food marketing has long been built around gives way to something more deliberate.
That presents an opportunity, not a threat, for food brands willing to think about it properly. UK retailers have been moving in this direction already. High-protein ranges have expanded across Aldi, Tesco, Sainsbury’s and Marks & Spencer, and the language around satiety and nutrition has become more prominent in product positioning. The next step for savvy brands is connecting that positioning explicitly to the mindset shift GLP-1 culture represents, without making the medication the story. Part of the audience has changed. The product brief can also change with it.
Wellness has a new register
The wellness sector is navigating this with particular energy. Brands that built their identity around weight loss, whether through clean eating plans, calorie-tracking apps or transformation-focused fitness content, are finding that the old language lands differently now. ‘Results’ used to mean a before-and-after. That framing feels thinner (so to speak) when a prescription can deliver a comparable outcome.
The smarter wellness brands are pivoting toward what medication cannot easily provide: the feel-good architecture around health. Energy, sleep quality, strength, gut health, mental clarity. These are genuine and growing consumer priorities and they are not displaced by GLP-1 use; in many cases they are amplified by it. Brands that can speak to this broader definition of feeling well, rather than anchoring everything in a dress size, are finding a receptive audience. Boots have launched a campaign for its ‘Summer Club’, which focuses on a plethora of different body types, races and abilities. This shift to showcase real people, instead of picture-perfect influencers works well and allows their demographic to broaden.
A growing audience that looks different
What many social media users are increasingly vocal about is specific: the gap between the bodies brands present as aspirational and the bodies their customers actually live in. That tension predates GLP-1 culture, but these medications have sharpened it. Whilst GLP-1s are becoming more popular, a significant portion of consumers are not interested in weight-loss or becoming smaller, so brand activations cast entirely from narrow physical mould starts to look less like inspiration and more like a decision. Gone is the body-positive movement of the early 2020s, catapulting us straight back to the outdated ideation that skinny = better.
The backlash, when it comes, is swift and well-documented. UK audiences on TikTok and Instagram have become adept at calling out influencer lineups that feel homogeneous and the commentary travels fast. Critique of a recent campaign with M&S shows that users are paying attention to these ideals. They want to see diversity in content, despite many influencers and celebrities shrinking by the day. A 2024 Dove study found that only 3% of women in the UK feel represented in advertising. That figure has sat uncomfortably in the industry for a while. GLP-1 culture has given it new urgency. There are many creators who fit in diverse categories such as race, gender, disability and body type. In 2026, there is simply no excuse for brands to overlook this.
What this means for social strategy
Knowing your audience has shifted is one thing. Making sure your content reflects that is another. None of this requires brands to reference GLP-1s, take a position on weight loss medication or wade into contested health territory. It requires something simpler: paying attention to who your audience is now.
Casting decisions are the most visible place to start. A genuine audit of who appears in your brand content, what range of bodies and experiences is represented and whether that lineup bears any resemblance to your actual customer base.
Content briefs are less visible but equally important. Food content that only speaks to abundance, indulgence and effortless eating is addressing a narrower slice of the audience than it used to, especially with HFSS restrictions (UK laws designed to tackle obesity by restricting the promotion and visibility of foods and drinks High in Fat, Sugar, or Salt). Content that has considered choices, quality over quantity and honest nutrition sits alongside that rather than replacing it. The brands doing this well are not abandoning appetite; they are expanding what appetite looks like. A brand that has navigated HFSS changes well is Tunnocks, who’s recent ad focused on the lifecycle of their brand, whilst avoiding any mention of the biscuits whatsoever.
GLP-1 culture has exposed assumptions that were already under strain. The brands that treat this as a prompt to think more honestly about their audiences, their casting and their messaging will find themselves better positioned, not despite the shift, but because of it.
